These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 31064190)

  • 1. Dynamic Changes in Circulating MicroRNA Levels in Liver Cancer Patients Undergoing Thermal Ablation and Transarterial Chemoembolization.
    Zavadil J; Juráček J; Čechová B; Andrašina T; Slabý O; Goldberg N
    Klin Onkol; 2019; 32(Supplementum1):164-166. PubMed ID: 31064190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermal Ablation and Transarterial Chemoembolization are Characterized by Changing Dynamics of Circulating MicroRNAs.
    Andrasina T; Juracek J; Zavadil J; Cechova B; Rohan T; Vesela P; Paldor M; Slaby O; Goldberg SN
    J Vasc Interv Radiol; 2021 Mar; 32(3):403-411. PubMed ID: 33495063
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chemoembolization for Treatment of Hepatocellular Carcinoma - National Registry-Based Analysis.
    Rohan T; Andrašina T; Uher M; Matkulčík P; Zavadil J; Staňková M; Čechová B; Jandurová L; Válek V
    Klin Onkol; 2019; 32(Supplementum1):160-163. PubMed ID: 31064189
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circulating MiRNA-373 as a Predictor of Response to Super-selective Transarterial Chemoembolization Bridging Therapy in Hepatocellular Carcinoma Patients Awaiting Liver Transplantation.
    Tork ASE; Kamel AAF; Zaki MA; Abo El-Wafa RAH; El-Assar OS; Ibrahim Abdelkarem OA
    Asian Pac J Cancer Prev; 2023 Jan; 24(1):291-299. PubMed ID: 36708579
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association of serum microRNA expression in hepatocellular carcinomas treated with transarterial chemoembolization and patient survival.
    Liu M; Liu J; Wang L; Wu H; Zhou C; Zhu H; Xu N; Xie Y
    PLoS One; 2014; 9(10):e109347. PubMed ID: 25275448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma micoRNA-122 as a predictive marker for treatment response following transarterial chemoembolization in patients with hepatocellular carcinoma.
    Kim SS; Nam JS; Cho HJ; Won JH; Kim JW; Ji JH; Yang MJ; Park JH; Noh CK; Shin SJ; Lee KM; Cho SW; Cheong JY
    J Gastroenterol Hepatol; 2017 Jan; 32(1):199-207. PubMed ID: 27194671
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating miR-26a, miR-106b, miR-107 and miR-133b stratify hepatocellular carcinoma patients according to their response to transarterial chemoembolization.
    Ali HEA; Emam AA; Zeeneldin AA; Srour R; Tabashy R; El-Desouky ED; Abd Elmageed ZY; Abdel-Wahab AA
    Clin Biochem; 2019 Mar; 65():45-52. PubMed ID: 30653948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transarterial chemoembolization using drug eluting beads and subsequent percutaneous MR-guided radiofrequency ablation in the therapy of intermediate sized hepatocellular carcinoma.
    Hoffmann R; Rempp H; Syha R; Ketelsen D; Pereira PL; Claussen CD; Clasen S
    Eur J Radiol; 2014 Oct; 83(10):1793-8. PubMed ID: 25052871
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Thermal ablation combined with transarterial chemoembolization for hepatocellular carcinoma: What is the right treatment sequence?
    Hendriks P; Sudiono DR; Schaapman JJ; Coenraad MJ; Tushuizen ME; Takkenberg RB; Oosterveer TTM; de Geus-Oei LF; van Delden OM; Burgmans MC
    Eur J Radiol; 2021 Nov; 144():110006. PubMed ID: 34717187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilization of Next Generation Sequencing in Analysis of Circulating MicroRNAs as Predictive Biomarkers for Patients with Locally Advanced Rectal Carcinoma.
    Macháčková T; Grolich T; Fiala L; Procházka V; Škrovina M; Kala Z; Slabý O
    Klin Onkol; 2019; 32(Supplementum1):157-159. PubMed ID: 31064188
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiofrequency vs Microwave Ablation After Neoadjuvant Transarterial Bland and Drug-Eluting Microsphere Chembolization for the Treatment of Hepatocellular Carcinoma.
    Thornton LM; Cabrera R; Kapp M; Lazarowicz M; Vogel JD; Toskich BB
    Curr Probl Diagn Radiol; 2017; 46(6):402-409. PubMed ID: 28392205
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transarterial Chemoembolization Monotherapy Versus Combined Transarterial Chemoembolization-Microwave Ablation Therapy for Hepatocellular Carcinoma Tumors ≤5 cm: A Propensity Analysis at a Single Center.
    Chen QF; Jia ZY; Yang ZQ; Fan WL; Shi HB
    Cardiovasc Intervent Radiol; 2017 Nov; 40(11):1748-1755. PubMed ID: 28681222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Radiofrequency ablation plus drug-eluting beads transcatheter arterial chemoembolization for the treatment of single large hepatocellular carcinoma.
    Iezzi R; Pompili M; La Torre MF; Campanale MC; Montagna M; Saviano A; Cesario V; Siciliano M; Annicchiarico E; Agnes S; Giuliante F; Grieco A; Rapaccini GL; De Gaetano AM; Gasbarrini A; Bonomo L;
    Dig Liver Dis; 2015 Mar; 47(3):242-8. PubMed ID: 25577299
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Single-session transarterial chemoembolization combined with percutaneous thermal ablation in liver metastases 3 cm or larger.
    Kobe A; Tselikas L; Deschamps F; Roux C; Delpla A; Varin E; Hakime A; De Baère T
    Diagn Interv Imaging; 2022 Nov; 103(11):516-523. PubMed ID: 35715327
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of Existing Response Criteria in Patients with Hepatocellular Carcinoma Treated with Transarterial Chemoembolization Using a 3D Quantitative Approach.
    Tacher V; Lin M; Duran R; Yarmohammadi H; Lee H; Chapiro J; Chao M; Wang Z; Frangakis C; Sohn JH; Maltenfort MG; Pawlik T; Geschwind JF
    Radiology; 2016 Jan; 278(1):275-84. PubMed ID: 26131913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serum microRNA-210 as a predictive biomarker for treatment response and prognosis in patients with hepatocellular carcinoma undergoing transarterial chemoembolization.
    Zhan M; Li Y; Hu B; He X; Huang J; Zhao Y; Fu S; Lu L
    J Vasc Interv Radiol; 2014 Aug; 25(8):1279-1287.e1. PubMed ID: 24935355
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Survival of Patients with Colorectal Liver Metastases after Transarterial Chemoembolization Using Irinotecan-Eluting Microspheres: A Single-Center Retrospective Analysis Comparing RECIST 1.1 and Choi Criteria.
    Maraj T; Mirrahimi A; Dey C
    J Vasc Interv Radiol; 2023 Jun; 34(6):983-990.e1. PubMed ID: 36775014
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Possible Use of miR-223-3p as a Prognostic Marker in Transarterial Chemoembolization Treatment of Hepatocellular Carcinoma Patients.
    E Abdelaziz H; El-Guendy N; Radwan EM; Sharawi SK; El-Houseini ME; Abdel-Wahab AA
    Asian Pac J Cancer Prev; 2022 Dec; 23(12):4125-4135. PubMed ID: 36579994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Study on the effect of chemoembolization combined with microwave ablation for the treatment of hepatocellular carcinoma in rats.
    Vogl TJ; Qian J; Tran A; Oppermann E; Naguib NN; Korkusuz H; Nour Eldin NE; Bechstein WO
    Diagn Interv Radiol; 2017; 23(2):150-155. PubMed ID: 28185998
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of transarterial chemoembolization with radiofrequency ablation for unresectable Barcelona Clinic Liver Cancer stage 0/A hepatocellular carcinoma: a propensity score matching.
    Chen RX; Gan YH; Ge NL; Chen Y; Ma H; Wang Y; Zhang BH; Wang YH; Ye SL; Luo JF; Ren ZG
    J Gastroenterol Hepatol; 2016 Feb; 31(2):442-9. PubMed ID: 26259976
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.